We work hard to ease the way for people with cancer throughout their treatment journey and to offer choice and scientific based information to oncology specialists.
Cancer is a major cause of morbidity and mortality throughout the world. In the UK, every two minutes someone is diagnosed with cancer.1
Our medicines treat cancer and associated conditions like chemotherapy-induced neutropenia and breakthrough cancer pain.
In our portfolio of generic medicines, we have treatments for a wide range of cancer types. Our Specialty lines focus on chemotherapy-induced neutropenia, acute promyelocytic leukaemia and metastatic breast cancer.
1 http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence#heading-Zero [accessed 17.04.18].
2 Lonquex® (lipegfilgrastim) Summary of Product Characteristics.
3 Trisenox® (arsenic trioxide) Summary of Product Characterisitics.
4 Myocet® (doxorubicin) Summary of Product Characterisitics.
To access this section of the Teva UK Limited website you need to be a member of the healthcare profession
because the materials included in this area of our website are specifically prepared for that audience
To understand why that is - please visit: Working in a regulated environment
Please click on the appropriate button below to confirm that you are healthcare professional.
If you are not a healthcare professional, you will be taken to an area of the website that is appropriate for you.